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A selection of 43 Candida albicans isolates, chosen to represent the four major strain clades of the species and
also intraclade diversity, was screened for their virulence in the murine intravenous challenge model of C.
albicans infection, for a range of properties measurable in vitro that might relate to virulence, and for the
numbers of midrepeat sequences in genes of the ALS and HYR families. Heterozygosity at the mating type locus
and low whole-cell acid phosphatase activity and growth rate at 40°C were found to be significantly positively
associated with the most virulent isolates. Acid phosphatase activity and growth in 2 M NaCl were statistically
significant variables between clades by univariate analysis. Isolates in different clades also differed significantly
in midrepeat sequence alleles of ALS2, ALS4, ALS6, ALS7, ALS9, HYR1, and HYR2. There was no association
between the midrepeat alleles of any ALS or HYR gene and the virulence of isolates to mice. Genome-wide
transcript profiles of 20 isolates (5 per clade) grown under two conditions showed considerable variation
between individual isolates, but only a small number of genes showed statistically significant differential gene
expression between clades. Analysis of the expression profiles by overall strain virulence revealed 18 open
reading frames differing significantly between isolates of high, intermediate, and low virulence. Four of these
genes encoded functions related to phosphate uptake and metabolism. This finding and the significant
association between whole-cell acid phosphatase activity and virulence led us to disrupt PHO100, which
encodes a predicted periplasmic acid phosphatase. The pho100 mutant was mildly but significantly attenu-
ated in terms of survival curves in the mouse model. The study has extended the range of properties known to
differ between C. albicans clades and suggests a possible but minor role of phosphate metabolism in the
virulence of the species.
Candida albicans is the species most commonly associated
with superficial and disseminated Candida infections in hu-
mans. Isolates of C. albicans analyzed by multilocus sequence
typing (MLST) (38, 51) or DNA fingerprinting with the mod-
erately repetitive oligonucleotide Ca3 (5, 43, 48) can be as-
signed to subsets of closely related strain types, referred to, for
convenience, as clades (40, 48). The main clades to which
individual strains are assigned are essentially the same by both
typing approaches (38, 51), and approximately 70% of the
large numbers of C. albicans isolates typed so far belong to one
of the four largest clades, numbered 1 to 4 (38). There is,
therefore, concordance between the structures and sizes of the
DNA repeat sequences recognized by Ca3 and the single-
nucleotide polymorphisms determined by sequencing 7 among
approximately 6,000 open reading frames (ORFs) in C. albi-
cans.
The most self-evident associations between the four major
C. albicans clades and other properties are seen for geograph-
ical origins and for the presence of an intron in ribosomal
DNA—the so-called ABC type (33, 34). While there is no
absolute geographical association between any clade and a
definable area where a clade is endemic, a high proportion of
isolates within each clade usually originates from a broadly
definable region (5, 38, 43, 48, 51). Moreover, there are statis-
tically definable subsets of strains within the broader clade
groupings that show more specific geographical origins (50).
ABC typing of isolates shows a near-total predominance of
type A isolates in clades 1 and 2 and a majority of type B
isolates in clade 3 and of type C isolates in clade 4 (38).
Clade-specific associations extend to properties of potential
relevance to the role of C. albicans as human commensal and
pathogen. Isolates of C. albicans resistant to flucytosine are
found predominantly within clade 1 (44, 51). These clade 1
isolates also show a common mechanism of flucytosine resis-
tance, based on an amino acid change (R101C) in the FUR1
gene product, a ribosyltransferase enzyme (13, 23, 51). This
mutation is not found in flucytosine-resistant isolates from
other clades (13, 51). Amphotericin B resistance shows a less
well pronounced but statistically significant association with C.
albicans clades (4). Statistically significant differences between
clades have been found for the numbers of tandem repeat
sequences in alleles of the genes ALS3, ALS5, and ALS6,
members of a gene family that encode C. albicans surface
proteins that play a role in adhesion to host surfaces (41, 63).
The evidence clearly indicates that C. albicans major clades,
delineated by MLST or Ca3 typing, comprise strains that differ
in a number of properties not directly related to the particular
gene sequences or tandem repeat sequences that are used to
define their clade assignation. Each clade therefore comprises
strains that have evolved in a manner different from strains in
other clades. In this study we have prospectively tested a set of
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C. albicans isolates representing the four major clades for their
virulence in the murine intravenous (i.v.) challenge model of
C. albicans infection, for a range of phenotypic attributes, for
tandem repeat alleles in several genes encoding glycosylphos-
phatidylinositol-anchored proteins, and for their gene expres-
sion profiles under two growth conditions.
MATERIALS AND METHODS
Fungi and growth conditions. A panel of 43 C. albicans isolates was selected
from a panel typed by MLST (38) to provide representatives of the strains in
clades 1 to 4. The isolates (Table 1) were chosen to include, as far as possible for
each clade, examples from superficial anatomical sources and bloodstream iso-
lates, isolates from diverse geographical sources, examples of isolates homozy-
gous (a/a or /) at the MAT locus as well as the more common a/ types (38),
and a mix of types A, B, and C, where this was possible. The MLST data for these
43 isolates were reanalyzed in an P-distance dendrogram made by the un-
weighted-pair group method using arithmetic averages with phylogeny tested by
1,000 bootstraps in MEGA 3.1 software (25). For the isolates shown in Table 1,
the 14 isolates in clade 1 and the 8 isolates in clade 3 coclustered in separate
groups with 100% bootstrap values (Fig. 1). For the 10 isolates in clade 2 and the
11 isolates in clade 4, the bootstrap values for the cluster nodes were 90% and
86%, respectively (Fig. 1).
All isolates were maintained frozen in 50% glycerol at 80°C. Working sub-
cultures on Sabouraud agar (Oxoid, Basingstoke, United Kingdom) were main-
tained at 4°C for a maximum of 14 days. For preparation of inocula for all
experiments except where indicated otherwise, C. albicans isolates were grown as
yeast cells in 5-ml volumes of NGY medium (0.1% Neopeptone, 0.4% glucose,
0.1% yeast extract) at 30°C with constant rotation at 20 rpm (32).
Deletion of PHO100 from C. albicans SC5314 and construction of reintegrant
strains. The CaPHO100 gene was disrupted by the standard “ura-blaster” pro-
tocol (ura, uracil) (15). The disruption cassette was produced by amplifying two
regions of the gene by PCR; a 5 region, containing the start codon, was amplified
with primer pair DMPHO100_1 and DMPHO100_2 (Table 2), and a 3 region,
containing the stop codon, was amplified with primer pair DMPHO100_3 and
DMPHO100_4 (Table 2). Restriction digests of the 5 region by SacI and BglII
and the 3 region with SalI and SphI allowed the DNA fragments to be cloned
into digested pMB7 (15). Digestion of the resulting plasmid with SacI and SphI
released the disruption cassette. The disruption cassette consisted of the ura-
blaster cassette flanked by complementary sequences of 340 bp at the 5 end and
460 bp at the 3 end of PHO100. PHO100 was sequentially disrupted by trans-
formation of strain CAI-4 (15), with the Ura3 marker recycled by selection on
SD medium (0.67% [wt/vol] yeast nitrogen base with ammonium sulfate
without amino acids but with 2% glucose) containing 5-fluoroorotic acid (1
mg/ml) and uridine (50 g/ml). To overcome any problems with URA3 ex-
pression from the PHO100 locus (6), the Ura-minus null mutant (DMY001;
pho100::hisG/pho100::hisG) was transformed with StuI-digested CIp10 plas-























repetitionsc Median Mean  SD
YsU751d 1 69 Malaysia Urine A a/ 2.5  0.9 3 8.0 7.3  4.1 7.5  0.3 10.3  9.6
HUN92 1 37 UK Blood A a/ 2.1  0.7 3 28.0 23.0  7.8 4.1  1.9 2.0  4.9
FJ9 1 102 Fiji Oropharynx A a/ 2.4  1.3 3 15.5 16.5  5.5 7.1  1.3 6.0  4.8
RIHO9d 1 100 USA Blood A a/a 2.3  1.3 3 28.0 25.5  4.5 5.3  1.2 2.6  3.1
78/028 1 73 UK Oropharynx A a/ 1.9  0.3 3 28.0 28.0  0.0 3.3  1.4 3.2  3.4
AM2002/0087d 1 135 UK Blood A a/ 2.4  0.9 3 12.0 13.2  8.4 7.3  0.5 11.7  6.9
HUN96 1 116 UK Blood A a/ 2.0  0.3 3 28.0 28.0  0.0 4.0  2.2 1.7  3.6
AM2003-013 1 120 UK Oropharynx A a/ 2.3  0.9 3 11.5 13.7  8.0 6.4  1.4 5.2  6.4
AM2003-016 1 123 UK Oropharynx A a/ 1.8  0.5 3 28.0 24.3  9.0 5.4  1.0 2.8  2.5
J981301 1 60 USA Vagina A a/ 2.0  0.7 3 28.0 27.2  2.0 6.7  1.5 0.7  4.4
81/064d 1 129 UK Vagina A / 1.3  0.2 3 28.0 24.8  6.0 4.2  2.4 2.1  4.5
J981318 1 86 USA Vagina A a/ 1.9  0.4 3 6.5 6.7  1.6 6.6  0.3 13.2  4.6
J951361 1 44 UK Blood A a/ 2.1  0.2 2 5.0 5.3  1.6 6.1  1.6 15.1  4.6
SC5314d 1 52 USA Blood A a/ 1.8  0.3 3 7.5 6.8  1.6 6.0  1.0 15.7  2.2
AM2003/0089 2 155 UK Blood A a/ 1.5  0.3 2 11.0 16.0  9.4 4.9  2.7 1.4  4.6
IHEM16972 2 155 Rwanda Oropharynx A a/ 2.7  0.8 2 9.5 12.2  8.0 6.3  0.9 5.3  4.6
FC22 2 155 USA Vagina A a/ 2.3  0.2 2 12.5 13.8  5.6 7.0  0.8 2.4  3.1
IHEM16614d 2 206 Rwanda Oropharynx A a/ 2.6  0.6 2 7.0 7.3  1.4 6.4  0.6 9.9  3.3
AM2003/0100d 2 206 UK Blood A a/ 1.5  0.7 2 28.0 20.7  11.4 5.9  1.1 2.6  5.0
IHEM16945d 2 356 Rwanda Oropharynx A / 1.8  0.5 2 13.0 14.8  6.8 6.1  0.9 2.1  4.3
AM2004/0028 2 326 UK Oropharynx A a/ 2.7  0.6 2 22.0 20.3  8.1 6.1  1.7 0.4  2.9
AM2003/0182 2 225 UK Blood A a/ 2.3  0.8 2 22.0 22.0  5.4 6.6  0.9 0.3  3.5
AM2003/0191d 2 232 UK Blood A a/ 2.5  0.1 2 8.5 10.7  5.9 6.5  1.2 9.1  5.7
AM2003/0069d 2 194 UK Vagina A a/ 2.5  0.8 2 26.0 24.5  4.2 4.9  1.7 0.73.2
FC28d 3 159 USA Vagina B / 2.4  0.8 3 28.0 26.3  4.1 4.1  1.8 1.1  4.3
73/025 3 132 UK Vagina B a/ 2.4  0.0 2 13.0 14.0  6.5 6.9  0.7 3.2  3.3
J981315 3 56 USA Vagina B a/ 2.0  0.1 2 10.0 13.7  8.0 5.7  1.7 3.4  5.5
b30708/5d 3 186 UK Blood B a/ 3.2  0.9 2 8.0 12.8  8.8 5.6  0.9 3.3  3.3
T101d 3 236 Canada Oropharynx B a/a 2.7  0.8 2 13.5 13.7  3.3 6.3  1.0 2.6  2.6
J990102d 3 45 Belgium Vagina B a/ 2.5  0.1 2 7.0 6.5  0.8 7.1  0.3 10.3  4.3
AM2003/0074 3 198 UK Blood B a/ 2.1  0.0 2 28.0 27.3  1.6 6.0  1.2 1.1  5.0
AM2003/0165d 3 332 UK Blood B / 1.5  0.4 2 26.5 21.7  9.0 4.2  2.2 0.2  6.0
s20152.082 4 168 USA Blood C a/ 2.6  0.9 3 14.5 14.7  5.5 7.2  0.4 8.0  9.8
s20152.013 4 167 USA Blood A a/ 2.3  0.3 3 20.0 19.3  9.5 6.1  1.6 10.7  7.7
AM2005/0377d 4 635 South Africa Blood B a/a 2.0  0.0 2 28.0 28.0  0.0 5.7  0.7 2.4  3.5
s20176.079 4 164 USA Blood A a/ 1.8  0.3 3 21.0 20.7  7.5 6.0  1.5 0.8  8.5
RV4688d 4 87 Zaire Blood C a/ 3.3  0.2 3 28.0 28.0  0.0 5.3  2.1 0.3  3.6
HUN68 4 95 UK Oropharynx B a/ 1.8  0.6 3 28.0 23.2  7.5 6.1  1.4 0.8  3.6
s20122.073 4 95 Switzerland Blood B a/ 1.8  0.4 3 5.0 12.5  12.0 6.0  1.8 8.6  11.1
L1086 4 144 Saudi Arabia Wound B a/ 2.9  0.6 3 10.0 10.7  3.1 7.3  0.4 7.3  5.5
IHEM3742d 4 124 Zaire Blood C a/ 1.9  0.4 3 28.0 28.0  0.0 5.1  2.2 1.8  3.6
s20175.016d 4 124 Israel Blood C a/ 2.3  0.1 3 28.0 26.2  3.0 6.9  1.2 7.0  5.9
AM2003-020d 4 124 UK Oropharynx C a/ 2.8  0.6 3 12.0 13.2  8.9 7.1  0.8 9.9  4.4
a DST, diploid sequence type.
b UK, United Kingdom; USA, United States of America.
c The isolate was tested in two groups of three mice (shown as 2) or tested in three groups of two mice (shown as 3).
d These isolates were used for expression profiling experiments.
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mid (35), which leads to URA3 expression at the RPS1 locus (DMY002; as
DMY001 but RPS1/rps1::CIp10). Correct disruption of the PHO100 alleles was
analyzed by PCR (primer pair DMPHO100_1 and DMPHO100_5) and con-
firmed by Southern analysis. A reintegrant strain for use as a control was created
by PCR amplifying the entire PHO100 ORF plus 885-bp promoter and 454-bp
terminator sequences (primer pair DMORF_1 and DMORF_2), and cloning it
into the pGEM-T vector (Promega Ltd., Southampton, United Kingdom). The
insert was released by NotI digestion and cloned into the NotI site in CIp10. The
resulting plasmid was digested with StuI and used to transform the Ura-minus
pho100 null strain (DMY003; as DMY001 but RPS1/rps1::CIp10-PHO100).
The control strain for these experiments was NGY152 (6), which is strain CAI-4
transformed with StuI-digested CIp10.
Virulence testing. The pathological effects of the 43 C. albicans isolates were
determined by murine i.v. challenge in groups of six animals. All animal exper-
imentation was done in accordance with United Kingdom Home Office regula-
tions and was approved by both the Home Office and an institutional ethical
review committee. Female BALB/c mice (Harlan, United Kingdom) (weight
ranging from 18 to 22 g) were maintained in groups of up to 12 animals per cage;
each animal was individually marked by staining fur with picric acid solution, and
the mice were weighed daily. The mice were supplied with food and water ad
FIG. 1. Dendrogram showing the similarity clusters (referred to as clades [shown to the right of illustration]) for the 43 C. albicans clinical
isolates used in this study. The dendrogram was constructed by the unweighted-pair group method using arithmetic averages with MEGA 3.0
software as previously described (50). The numbers at nodal points indicate bootstrap values (as percentages) for 1,000 replications. The scale bar
at the bottom of the figure shows nucleotide substitutions.
VOL. 8, 2009 C. ALBICANS CLADE PROPERTIES 375
libitum. For preparation of challenge inocula, cells grown in NGY medium were
harvested by centrifugation, washed, and resuspended in sterile physiological
saline. Yeast counts were adjusted with a hemocytometer to a density such that
animals received an i.v. challenge dose of 2 104 CFU per g of body weight. The
actual numbers injected were determined the following day by counting the
viable cells of the inoculum suspensions. The actual range of challenge doses for
the 43 isolates was 1.5  104 to 3.3  104 CFU/g; the median and modal doses
were both 2.3  104 CFU/g. To keep the numbers of mice infected as low as
possible, i.e., groups of six mice, while acknowledging the possibility of batch-
to-batch variation in outcomes of challenge, the fungal isolates were each in-
jected either in two mice on three separate occasions or in three mice on two
separate occasions (detailed in Table 1).
The mice were observed for up to 28 days postchallenge and were humanely
terminated when their body weight fell more than 20% below their initial weight
or when the animals showed signs of serious illness. The dates of termination of
animals were used to determine survival after challenge. At the time of death,
both kidneys were dissected with aseptic precautions and homogenized together
in 0.5-ml volumes of sterile water, and tissue burdens were measured by counting
the viable cells on Sabouraud agar. The percent change in body weight of each
mouse between the day of challenge and 3 days postchallenge was calculated
relative to the weight of the mouse on the day of challenge.
The same model was used to test virulence of the pho100mutant, but a single
experiment was done with groups of six mice challenged i.v. with control and
mutant strains.
Measurement of phenotypic properties. Several phenotypic properties were
characterized for all 43 C. albicans isolates. For all phenotypic tests, cultures of
each isolate were grown in 5 ml of NGY medium overnight at 30°C with constant
rotation. Cells were harvested and washed with sterile water prior to use in
phenotypic tests. Where required, cell numbers were determined by counting
cells with a hemocytometer.
Biofilm formation was measured by resuspending cells in RPMI 1640 medium
containing 10% (vol/vol) serum (RPMI 1640–10% serum) (1 RPMI 1640
medium, 2 mM L-glutamine, 1.65 mM morpholinepropanesulfonic acid [MOPS],
10% fetal calf serum) to a density of 2  106 cells/ml in triplicate wells of a
24-well tissue culture plate. Plates were incubated overnight at 37°C in 5% CO2
without agitation. Biofilm formation was gauged by reading the optical density at
600 nm (OD600) of the supernatant after agitation.
Germ tube formation and mean morphology index were determined for cells
incubated for 3 h in fetal calf serum. Washed cells (3  106) were resuspended
in 1 ml of 100% fetal calf serum (prewarmed to 37°C) and incubated in a 37°C
water bath for 3 h. The cultures were fixed with formalin, and the morphology of
cells was determined microscopically. For each strain, the morphology index was
determined on three separate occasions.
For measurement of growth under proteinase-inducing conditions, overnight
cultures in NGY medium were washed twice in sterile water and reinoculated
into 5-ml volumes of 1.17% yeast carbon base (Difco)—1% glucose and 0.5%
bovine serum albumin (Sigma) at an initial concentration of 104 yeasts/ml.
Cultures were incubated for 72 h at 30°C with constant rotation. Turbidity ODs
were measured versus a medium blank at 600 nm.
Acid phosphatase activity was determined in intact C. albicans cells. These
cells were grown in phosphate-free NGY medium for 16 h, washed once in water,
and resuspended in water to one-fifth of the original culture volume. Enzyme
activity was measured by the following modification of the method of Lindhardt
and Walter (29). The final reaction mixture contained 50 l of 5.5 mM p-
nitrophenyl phosphate (ICN Biomedicals Inc., United Kingdom) in 0.11 M
citrate buffer (pH 5.0) and 5 l cell suspension. The reaction in control wells was
immediately stopped by the addition of 245 l of 0.1 M NaOH. The plate was
incubated for 15 min at 37°C, and then the reaction was stopped with the
addition of NaOH to the remaining wells. The absorbance of the yellow p-
nitrophenyl released was measured at 405 nm, and the amount of p-nitrophenol
released was calculated from a standard curve. Experimental measurements were
corrected by subtraction of control measurements. Specific activity was defined
as nanomoles of p-nitrophenol/15 min/OD600 in the cell suspension.
Alcian blue binding to surface charged groups was measured for yeast cells
grown in YPD (1% yeast extract, 2% mycological peptone, 2% glucose) at 30°C
for 18 h with constant rotation according to the method of Hobson et al. (21). For
each assay, 50 l of cell suspension (	1.5  107 cells) was harvested, washed in
water, and resuspended in 1 ml of 30 g/ml alcian blue in 20 mM HCl. The cell
suspensions were incubated for 10 min at room temperature, and then the cells
spun down. A620 values were determined for the supernatants, allowing the
amount of alcian blue bound by the cells in the assay to be determined from a
standard curve. Specific alcian blue binding was expressed as micrograms of
alcian blue bound per OD600 unit of cells.
The growth rates of cells in RPMI 1640 medium were determined by adding
10 l of washed C. albicans cells to 5 ml RPMI 1640 with low MOPS (1 RPMI
1640, 2 mM L-glutamine, 1.65 mM MOPS [pH 6.5]). For each strain, 200 l of
cell suspension was dispensed into triplicate wells of 96-well flat-bottomed tissue
culture plates. Growth curves were plotted at 40°C over 16 h by means of a
Fluostar Optima plate reader (BMG Labtech Ltd., Aylesbury, United Kingdom).
Growth rates were calculated from the exponential region of the growth curve
and were recorded as means from the growth rates determined on three separate
occasions.
To measure NaCl tolerance, 10 l of washed C. albicans cells was added to 5
ml 2RPMI 1640 with low MOPS (1RPMI 1640, 2 mM L-glutamine, 1.65 mM
MOPS [pH 6.5]), and 100-l lots were dispensed into wells containing 100 l 4
M NaCl, such that tolerance to 2 M NaCl was assayed. For each C. albicans
isolate, triplicate wells were assayed on at least two occasions.
Adherence of fungi to BECs and catheter material. Buccal epithelial cells
(BECs) were collected by scraping the gums and cheeks of healthy donors,
washed, and resuspended (3  105 cells/ml) in physiological saline. Cells were
monitored microscopically for prior colonization by yeast cells. Washed C. albi-
cans cell suspensions were adjusted to 5 106 cells/ml in saline. Adherence assay
solutions (600 l) contained 6  104 BECs mixed with 1  106 C. albicans cells.
The solutions were incubated at 30°C with constant rotation for 1 h. The number
of C. albicans cells adherent to each BEC was determined microscopically, with
at least 100 BECs examined for each assay. Assays were performed for each
strain on at least three separate occasions.
Adherence to catheter material was measured by the method of Seidler et al.
(47). Arrow-Howes Hands-Off multilumen central venous catheters (radiopaque
polyurethane) were a kind gift from Nigel Webster, University of Aberdeen.
Briefly, catheters were cut into 5-mm sections and weighed. Catheter pieces were
preconditioned in 100% fetal calf serum at 37°C with agitation overnight. Cath-
eter material was washed twice in phosphate-buffered saline and then immersed
in 1 ml C. albicans cell suspension (2  106 cells/ml in RPMI 1640–10% serum),
and the cell suspension containing catheter material was incubated for 2.5 h at
37°C with shaking to allow adherence. Sections were washed three times with
phosphate-buffered saline and then added to 1 ml RPMI 1640–10% serum, and
the catheter culture was incubated for 24 h at 37°C under 5% CO2. At this time,
cell growth in catheter culture was estimated using Alamar Blue (AbD Serotec,
TABLE 2. Oligonucleotide primers used for gene disruption and screening of C. albicans PHO100
Primer Target Oligonucleotide sequence (533)a
DMORF_1 Reintegrant cassette amplification ATTAAGGAATCGGCTGCC
DMORF_2 Reintegrant cassette amplification CATGTCGTCTATCAGTCATCC
DMPHO100_1 Amplification of 5 region (contains a SacI site) GACTGAGAGCTCGCAATGAGATTTGTTTAC
DMPHO100_2 Amplification of 5 region GAGGCTGGAGTACCGTTG
DMPHO100_3 Amplification of 3 region (contains a SalI site) AGCCTTGTCGACGGTCTCGGTGTTGGTTTG
DMPHO100_4 Amplification of 3 region (contains a SphI site) CTGAAGGCATGCGTGACGATAAAGGAAGCG
DMPHO100_5 Screening for gene disruption TGACCAGTCAATCTAGTG
a Restriction sites in primer sequences are underlined.
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Oxford, United Kingdom) by measuring the percent reduction Alamar Blue per
gram catheter plastic.
Expression profiling. From the full panel of 43 C. albicans isolates, a subset of
20 was chosen for inclusion in expression profiling experiments. The subset
comprised five isolates from each of the four clades, selected to represent as
much diversity as possible with respect to mouse virulence, MAT homozygosity,
and ABC type (Table 1).
For expression profiling, cells were grown either in NGY medium at 30°C or
in RPMI 1640–10% serum at 37°C. For NGY-grown cells, an NGY preculture
was used to inoculate 100 ml NGY at 30°C to an initial OD600 of approximately
0.15. Cells were grown with constant shaking at 200 rpm until they reached an
OD600 of approximately 0.8. For cells grown in RPMI 1640–10% serum, 1 ml of
an NGY preculture was harvested and the cells were washed and resuspended in
1 ml distilled H2O. This was used to inoculate 120 ml RPMI 1640–10% serum at
37°C in a tissue culture flask. Cultures were incubated at 37°C under 5% CO2 for
16 h without agitation. Cells were scraped off the flask surface and resuspended
in medium. For both growth conditions, cells were harvested by centrifugation,
resuspended in residual liquid, and flash-frozen in liquid nitrogen. RNA was
extracted by the method of Hauser et al. (20). The quality of the RNA was
analyzed by agarose gel electrophoresis, and RNA concentration was measured
by spectrophotometry. For each isolate under each growth condition, three
independent cultures were grown for RNA extraction.
For cells grown in both NGY medium and RPMI 1640–10% serum, SC5314
RNA samples were used to prepare a pooled control, which consisted of equal
quantities of RNA from each of the three samples processed. The pooled control
was used for comparison with each isolate, including SC5314. Labeled cDNAs
were prepared (11), with 25 g isolate RNA labeled with Cy3 and 25 g pooled
control labeled with Cy5. For each isolate and growth condition, three microar-
rays were carried out comparing the three independent RNAs extracted to the
relevant pooled control. Microarray hybridizations, washes, and scanning and
acquisition of data were performed as described previously (11).
The results of the expression profiling exercise were two sets of triplicate data
for 20 C. albicans isolates, each grown in NGY and RPMI 1640 media and
profiled with reference to pooled RNA from C. albicans SC5314 triplicate cul-
tures grown under the same conditions. The data were normalized on a per spot
and per chip intensity-dependent (Lowess) basis and on a per chip basis to the
50th percentile, and then the expression ratios were converted to base 2 loga-
rithms. The Statistical Analysis of Microarrays (SAM) (54) software package
(http://www-stat.stanford.edu/	tibs/SAM/) was used to determine significantly
differentiated genes between groups of isolates. The analyses were done with
expression profile data grouped in three strata according to overall virulence and
in four strata by clade; multiclass SAM comparisons were done between strata.
For each analysis, two approaches were used. In the first, the triplicate data were
analyzed directly. In the second, a proprietary computer script was used to
exclude the most extreme outlier among each set of triplicates, and SAM analysis
was then applied to the most concordant pair from the three data for each gene
and isolate. Data sets used in the SAM analysis are provided as tables in the
supplemental material. Genes were considered to contribute significantly to
differentiation between clades and virulence groups when their q value by SAM
was 
0.05. Only genes that emerged as significant multiclass differentiators from
both the triplicate and the “best two of three” data sets were recorded as likely
to represent differences in constitutive gene expression between the strata ana-
lyzed. Transcript profiling data can be accessed via ArrayExpress (http://www
.ebi.ac.uk/microarray): identification numbers E-MEXP-1933 (RPMI 1640 data)
and E-MEXP-1931 (NGY data).
ALS and HYR tandem repeat determinations. For approximation of the num-
ber of tandem repeats for ALS and HYR genes, genomic DNA was extracted
from each of the 43 C. albicans isolates (22). PCR mixtures (50 l) containing
100 ng genomic DNA, 0.4 M forward and reverse primers, and 1 PCR
Mastermix (Thermoscientific, Epsom, Surrey, United Kingdom) were set up for
each isolate. Oligonucleotide primer sequences are listed in Table 3. PCR was
performed as follows: one step of 1 min at 94°C, followed by 30 cycles (1 cycle
consisting of 1 min at 94°C, 1 min at 50°C, and 3 min at 72°C), with a final step
of 10 min at 72°C. PCR products were analyzed by agarose gel electrophoresis
against appropriate molecular weight DNA markers (Promega UK, Southamp-
ton, United Kingdom).
Statistical analysis of data. SPSS for Windows version 16.0 was used for all
statistical analyses. Associations between virulence parameters, such as mean
survival times or terminal kidney burdens, and other properties measured for the
43 C. albicans isolates were determined by two-step multiple regression analyses
with the SPSS general linear model. The virulence parameter was set as the
dependent variable and other properties were input as fixed factors or covariates,
according to their type (nominal or continuous variables). The model was set to
show the significance of the contribution of each property to main between-
subject effects. The four properties with the lowest P values in this first analysis
were then reevaluated together to determine which properties still showed a
significant association with the virulence parameter being tested. Associations
between virulence designations (a nominal variable from 1 to 3 corresponding to
high, intermediate, and low overall virulence, respectively), clade assignations,
and other properties were determined by the Kruskal-Wallis test for K indepen-
dent variables. Correlations between data sets were determined by Spearman’s
parametric r coefficient and by Kendall’s nonparametric tau. Because a large
number of statistical tests was performed, outcomes were judged as statistically
significant only when the probability P that the result occurred by chance was

0.01 in order to avoid type 1 statistical errors. Instances of associations with
P 
 0.05 but  0.01 were noted as possibly significant.
For analysis of associations between tandem repeat data and clades, two
approaches were used. In the first, results for each isolate were represented as
the average number of repeats between the diploid alleles for each isolate; in the
second, each allele was analyzed individually, so each isolate was represented in
duplicate. The Kruskal-Wallis test was applied in both cases.
Differences in mouse survival were tested by Kaplan-Meier/log rank analyses,
and differences in body weight changes and mouse kidney burdens were tested by
the Mann-Whitney U test.
RESULTS
Virulence of 43 C. albicans isolates in mice. The three pa-
rameters related to virulence of each isolate, namely, kidney
burden, mean survival time (MST), and weight loss over the
first 3 days of infection, are summarized in Table 1. Across the
43 isolates, statistically significant correlations (all P
 0.001 by
both Spearman’s r and Kendall tau) were found between the
three parameters of virulence shown in Table 1. For mean
terminal log CFU/g kidney (kidney burden) versus MST, the
statistics were r0.59 and   0.43. For mean percentage
body weight change from day 0 to day 3 (weight change) and
kidney burden, the statistics were r  0.62 and   0.50,
and for weight change and MST, the statistics were r  0.79
and   0.65. The strongest correlation was between weight
change and MST (Table 1; Fig. 2), suggesting that the loss of
body weight over the first 72 h postinfection was a suitable
marker for MST in the BALB/c mouse i.v. challenge model as
described in this study. Weight changes over periods shorter
TABLE 3. Oligonucleotide primers for analysis of cell wall gene
repeat regions
Primera Target Oligonucleotide sequence (533)
ALS1RFw ALS1 tandem repeat region GATTCAATTGACACAGTG
ALS1RRv ALS1 tandem repeat region TCTTTGAACTTGACATGC
ALS2RFw ALS2 tandem repeat region GTCATTGTTGCTACAACCCG
ALS2RRv ALS2 tandem repeat region ATGACACTATTGGTGCCACC
ALS3RFw ALS3 tandem repeat region CTGCTACAGATGTTAATTCG
ALS3RRv ALS3 tandem repeat region GTTGGTGTAATGAGGACGAG
ALS4RFw ALS4 tandem repeat region CCAGTGAATGGACAGGAACA
ALS4RRv ALS4 tandem repeat region ATTGCCACGCTTGTTTTACC
ALS5RFw ALS5 tandem repeat region TCCACTTCCAAATCCAAC
ALS5RRv ALS5 tandem repeat region TATACTTGATGACTGCTC
ALS6RFw ALS6 tandem repeat region GTTGTACAAGTTCCACTG
ALS6RRv ALS6 tandem repeat region TATACTTGAAGTCTCGTC
ALS7RFw ALS7 tandem repeat region CAGCGACAACCACTTACTTCG
ALS7RRv ALS7 tandem repeat region CCCAATTGAGCTTGATGGAA
ALS9RFw ALS9 tandem repeat region TGACGGGGATGTGATCGTAG
ALS9RRv ALS9 tandem repeat region ATCCAGTTCCGAGTGCAGGT
HYR1RFw HYR1 tandem repeat region GGAGGTAATGAAAGTGGTTC
HYR1RRv HYR1 tandem repeat region CCTTCATTAGAACCAGAGTG
HYR3R1Fw HYR3 tandem repeat region 1 TCAGTTAGTGCTTCAGCAGC
HYR3R1Rv HYR3 tandem repeat region 1 CTCTTACATACAACAGGAGG
HYR3R2Fw HYR3 tandem repeat region 2 AGTCTTGAAACACCTGTCCC
HYR3R2Rv HYR3 tandem repeat region 2 TGATGGAACAACCGAGAGTG
a Forward primers and reverse primers are indicated by Fw and Rv suffixes,
respectively, at the end of the primer name.
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than 3 days correlated less effectively with survival times, and
from day 4 onwards, mice in some groups began to succumb to
infection, resulting in missing data for purposes of analysis.
Our use of a 20% fall in body weight as a criterion to determine
need for euthanasia of the mice might be thought to have
contributed artifactually to the weight change-survival correla-
tion. However, it is clear from Fig. 2 that none of the mean
weight changes for the 43 isolates tested reached the 20%
level, and therefore, few of the individual weight changes were
of this magnitude. Correlations between challenge inoculum
and MST, kidney burden, or weight change were all statistically
insignificant.
The C. albicans isolates could be ranked for murine viru-
lence on the basis of the three parameters shown in Table 1,
alone or in combination. The ranking approach showed that 14
isolates could be scored as the most consistently virulent in
mice by all parameters; 14 could be scored as the least virulent
for mice, and the remaining 15 isolates were designated as
having “intermediate” mouse virulence (Table 4). There was
no obvious association between strain clades and murine vir-
ulence.
Associations between virulence in mice and other properties
of C. albicans isolates. A range of tests in vitro was applied to
the 43-isolate panel to determine whether any property was
associated with the virulence of each isolate (Table 4). By the
Kruskal-Wallis K-sample test, the data in Table 4 showed a
significant association between overall virulence rank and
three other variables: MAT heterozygosity versus homozygos-
ity (P  0.038), acid phosphatase activity (P  0.019), and
growth rate at 40°C (P  0.004). There was no example of a
MAT-homozygous isolate among the 18 most virulent isolates
(Table 4). The most virulent isolates tended toward lower acid
phosphatase activity: the phosphatase activities (nanomoles/15
min/OD600) (mean  standard error of the mean [SEM]) were
367  45, 470  64, and 890  190 for the sets of isolates
ranked as having high, intermediate, and low virulence, respec-
tively. Finally, the most virulent set of isolates had the highest
growth rates in RPMI 1640 medium (mean  SEM) at 40°C
(  0.16  0.01 h1 for the 14 most virulent isolates versus
0.12  0.01 for the other two groups).
The three variables found to show statistically significant
associations with the overall virulence ranking also emerged as
significant factors in multiple regression analysis of individual
virulence parameters. For MST as the dependent variable, acid
phosphatase activity (P  0.007) and growth at 40°C (P 
0.005) were the only two significantly associated variables in a
two-step regression analysis. With weight change as the depen-
dent variable, acid phosphatase activity (P 0.003) and growth
at 40°C (P  0.003) again emerged as the most significant
among the four originally most significant variables, although
in this analysis, the clade (P  0.025) also showed a possibly
significant association. Finally, the analysis with kidney burden
as the dependent variable showed only MAT heterozygosity
(P  0.002) as a significantly associated factor.
Associations between the clade and other properties of C.
albicans isolates. Kruskal-Wallis analysis of the data (Table 4)
for tests in vitro with the C. albicans clade as the grouping
variable showed significant associations between the clade and
acid phosphatase activity (P  0.002), ABC type (P 
 0.001),
and growth in 2 M NaCl (P 
 0.001). The percentage of BECs
with C. albicans attached (but not the average numbers of C.
albicans attached to BECs) showed a possibly significant asso-
ciation with clade (P  0.033). Only 4 of the 43 isolates made
poor or no biofilms on polystyrene under the conditions of the
experiment: all were from clade 4, but this association was not
significant in the Kruskal-Wallis analysis (P  0.056). Table 5
summarizes the results of the tests done in vitro, stratified by
clade. Data on MAT heterozygosity were not included, since
the proportion of homozygous and heterozygous isolates de-
pended on the choice of isolates. The data on ABC type were
included as a positive control for validation of the statistical
analysis. ABC types A, A, and B are already known to correlate
strongly with clades 1, 2, and 3, respectively (38). The associ-
ation of acid phosphatase activity with clades appeared largely
as a generally lower level of activity among clade 2 isolates
(Table 5). For clade 2 isolates, mean acid phosphatase specific
activity was 249 41 units compared with 735 192, 603 79,
and 640  113 units for isolates in clades 1, 3, and 4, respec-
tively. The association of growth in 2 M NaCl with clades was
largely the consequence of a much higher proportion of clade
1 isolates that grew at this salt concentration compared with
the other clades (Table 5).
ALS and HYR repeat sequences and their variation between
clades and with virulence. The 43 isolates showed differences
in the numbers of many of the ALS and HYR midrepeat se-
quences for the four C. albicans clades (Fig. 3). Self-evident
examples of interclade differences in repeat lengths included
ALS6, where isolates in clade 4 all contained at least one allele
with approximately twice as many repeats as all alleles in the
other three clades, ALS7, where isolates in clade 2 all con-
tained alleles with fewer repeats than for most isolates in the
other three clades, the first repeat of HYR3, where clade 3
isolates had uniformly homozygous alleles while almost all the
isolates in other clades were heterozygous for this repeat, and
the second repeat of HYR3, where there were fewer repeats in
the alleles of most isolates in clades 3 and 4 compared to
isolates from clades 1 and 2 (Fig. 3). The overall statistics for
midrepeat allele data in each clade are shown in Table 6. The
FIG. 2. Scatterplot of mean change in body weight over 3 days
postchallenge versus mean survival time for mice infected with 43 C.
albicans isolates. The regression line is shown. The Pearson correlation
coefficient r for the data was 0.79; Kendall tau (nonparametric corre-
lation coefficient) was 0.65. For both measures of correlation, P was

0.001.
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data were analyzed for statistically significant differences be-
tween clades by applying the Kruskal-Wallis test to alleles
considered independently and considered as means of the two
alleles per isolate. On the latter, highly conservative basis, the
probability that the differences in allele repeats between clades
were significant was 
0.05 for ALS3 and both HYR3 repeats
(Table 6). With the alleles analyzed as independent data by
clade, only results for ALS1, ALS3, and ALS4 failed to reach
the significance level of P 
 0.01.
Reanalysis of the midrepeat data grouped according to over-
all virulence class (Table 4) revealed no statistically significant
associations between midrepeat numbers and virulence group
(data not shown).
Expression profiling of 20 C. albicans isolates from clades 1
to 4. Five isolates selected from each of the four main C.
albicans clades were grown to late-exponential phase in NGY
and RPMI 1640 media. NGY is the medium used routinely in
this laboratory for growth of challenge inocula in the mouse
model of disseminated C. albicans infection; it supports the
growth of C. albicans purely in the yeast form. It was chosen
since the profile observed in this medium is that of cells im-
mediately before they infect experimental animals. RPMI 1640
is a tissue culture medium that mimics the composition of
human body fluids and is utilized in applications such as yeast
susceptibility testing (37). C. albicans cells grow as mixtures of
pseudohyphal and hyphal forms in this medium (7). For both
media, expression profiles for the 20 isolates were normalized
against the profile for pooled RNA from strain SC5314 grown
under the same conditions. The quality of the expression pro-
file data is illustrated in Fig. 4, which shows interpretation
graphs for two randomly chosen isolates each in clades 2 and 3
relative to the reference isolate SC5314. Here the relative
expression levels of all genes are depicted for 4 of the 20
profiled isolates and the reference isolate SC5314. Figure 4
shows that the replicate quality of the triplicate data was good,
and the triplicate SC5314 profiles showed only minor expres-
sion variations from the SC5314 RNA pool used to normalize
all the data. Figure 4 also illustrates the considerable interiso-
late diversity found in constitutive gene expression in the
present experiments. The expression levels depicted in Fig. 4
suggested extensive interclade gene expression differences, but
this level of differential expression was not sustained by anal-
ysis of expression profiles for all 20 isolates.
SAM analysis of the 20 expression profile sets stratified by
clade identified 134 genes providing multiclass interclade dif-
ferentiation with a q value of
0.05 for the 20 isolates grown in
NGY medium and 43 genes with a q value of 
0.05 for the
same isolates grown in RPMI 1640 medium. The average dif-
ferences in expression between significant genes in the multi-
class analyses were generally not large; hence, details for only
the 50 genes that gave the highest d scores by SAM in the NGY
experiment were scrutinized in detail (Fig. 5). Variation in
mean expression levels between isolates relative to the control
was greater for cells grown in NGY medium than for cells
grown in RPMI 1640 medium (compare Fig. 5a and b). Ex-
pression of many of the genes illustrated in Fig. 5a appeared to
relate particularly to clade 3 isolates, relative to isolates in
other clades (Fig. 5a). However, there was also substantial
intraclade variation in the levels of expression of many of the
genes that emerged from the multiclass SAM analysis for
NGY-grown cells.
The same was not true for cells grown in RPMI 1640 me-
dium (Fig. 5b), where gene expression differences within clades
were mostly minor. The five clade 1 isolates, in particular,
showed high similarity of expression levels for all of the genes
found to be significant contributors to interclade differentia-
tion by SAM analysis (Fig. 5b). Once again, expression levels in
clade 3 appeared to offer the most distinctive interclade ex-
pression differences.
SAM analysis of the expression profiling data stratified by
mouse virulence phenotype (Fig. 6) determined significant
multiclass differentiation for 21 ORFs (22 microarray spots) in
NGY-grown cells. On the list of differentially expressed genes
between the three groups (based on overall virulence ranking;
TABLE 5. Summary of results for strain properties and tests in vitro for isolates in each of the four main C. albicans clades
Strain property or test result
Value for isolates in:
Clade 1 (n  14) Clade 2 (n  10) Clade 3 (n  8) Clade 4 (n  11)
Type A,a no. of isolates (% of clade) 14 (100) 10 (100) 0 (0) 2 (18)
Type B,a no. of isolates (% of clade) 0 (0) 0 (0) 8 (100) 4 (36)
Type C,a no. of isolates (% of clade) 0 (0) 0 (0) 0 (0) 5 (45)
max (mean  SEM) (h
1) in RPMI 1640 at the following temp:
30°C 0.15  0.01 0.16  0.01 0.16  0.01 0.14  0.01
37°C 0.23  0.01 0.20  0.01 0.22  0.02 0.22  0.02
40°C 0.13  0.01 0.15  0.01 0.13  0.01 0.13  0.01
Biofilm formation (mean  SEM) (supernatant OD600) 0.017  0.004 0.027  0.006 0.037  0.030 0.191  0.095
Growth (mean  SEM) (OD600) in YCB-BSA
b at 30°C 0.13  0.13 0.36  0.07 0.27  0.17 0.37  0.14
Acid phosphatase sp acta (mean  SEM) (nmol/15 min/OD600) 740  190 250  40 600  80 640  110
Alcian blue (mean  SEM) (g bound per cell OD600) 94  6 110  10 80  2 90  9
Growth in 2 M NaCl,a no. of isolates (% of clade) 13 (93) 4 (40) 1 (13) 2 (18)
No. of BECs positive for C. albicans (mean  SEM) 28  1.4 27  1.9 35  2.5 26  1.6
No. of C. albicans per BEC (mean  SEM) 2.0  0.1 2.0  0.1 2.1  0.2 1.8  0.1
Adherence to catheter plastic (mean  SEM) (% reduction Alamar
blue per g catheter)
1.2  0.1 1.2  0.1 1.3  0.1 1.2  0.1
a These properties were significantly different between clades (Kruskall-Wallis test, P 
 0.01).
b YCB-BSA, yeast carbon base with bovine serum albumin.
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Table 4), genes with reference numbers CA0636 (FDH4.3F),
CA0639 (FDH13.3F), and CA3258 (IFC2) are no longer ac-
cepted in the current assembly (assembly 21) of the C. albicans
genome database (CGD) (http://www.candidagenome.org/).
Our finding of differential expression of these ORFs suggest
that they may in fact be valid for inclusion in the database.
Figure 6 lists the 18 significant and currently accepted genes
(one significant gene was represented twice on the arrays, so
that the list contains 19 entries) with multiclass differential
expression based on the overall virulence of the 20 C. albicans
isolates. For RPMI 1640-grown cells, only two genes (ORFs
19.6847 and 19.3075; Fig. 6) met the criteria for inclusion as
differentially expressed between isolates in virulence groups 1,
2, and 3.
The data in Fig. 6 showed that four genes involved in phos-
phate uptake, metabolism, and storage were among those with
expression significantly differentially associated with virulence.
These genes were PHO84 (encoding a protein with similarity to
high-affinity phosphate transporters; 26), PHO87 (encoding a
protein similar to phosphate permeases; 26), PHO100 (encod-
ing an inducible acid phosphatase; 18), and VTC4, (encoding a
polyphosphate synthase; GO annotation, CGD). Other genes
with expression significantly different between the three viru-
lence groups were cell cycle genes CDC3 (a yeast neck septin;
12, 55) and CDC5 (involved in filamentous growth; 2), MET2
(encoding a homoserine O-acetyltransferase; 16, 52), LAP3 (en-
coding an aminopeptidase; 27), and oligopeptide transporter-en-
coding genes IFC1 and IFC3 (31, 45). It should be noted (see
above) that CA3258, another significant gene in our expression
array, was formerly known as IFC2.
FIG. 3. Alleles of midrepeat sequences for genes in the ALS and HYR families. For each of 43 C. albicans isolates, the number of sequence
repeats (shown on the y axis) is indicated by a line joining the repeat numbers for the two alleles of each gene. A horizontal line thus indicates
homozygous repeats of the numbers indicated in the y axis. A diagonal line indicates an isolate with heterozygous repeats, with the larger of the
two allele repeats indicated by the left-hand position of the line. For isolates with identical allele pairs, the results have been jittered vertically to
make each isolate line visible. The isolate data are grouped in columns representing results for isolates in clades 1, 2, 3, and 4. Note that some y
axes have been compressed to emphasize interclade differences.
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Characterization of a pho100 mutant in vitro and in vivo.
Because the expression profiles possibly associated with vir-
ulence contained three upregulated genes associated with
phosphate uptake or metabolism, we elected to delete
PHO100, which encodes a predicted periplasmic acid phos-
phatase enzyme (http://www.candidagenome.org). We rea-
soned that, in this surface location, the phosphatase may be
directly involved in host-C. albicans interactions. Yeast cells
of the pho100 mutant showed elevated acid phosphatase
activity in vitro (specific activities of the mutant and
pho100::rps1::CIp10-PHO100 reintegrant strains were, re-
spectively, 219% [29%] and 114% [37%]) relative to the
control strain CAI-4 carrying plasmid CIp10.
In the mouse intravenous challenge model, the pho100
mutant showed modest but statistically significant attenuation
of virulence in terms of time to euthanasia (Fig. 7) relative
both to the CAI-4 control strain with CIp10 (P 
 0.01) and to
the pho100::PHO100 reintegrant (P 
 0.05). There were no
statistically significant differences in percent weight changes
between day 0 and day 3 (means  standard deviations [SDs]
were 8.5%  4.8%, 13.9%  3.1%, and 10.1%  3.1%,
respectively, for the mutant, CAI-4 control strain with CIp10,
and reintegrant strain). Similarly, no significant differences
were found between the three strains in terms of kidney fungal
burdens at the time of demise. (The log10 CFU/g tissue data
were as follows: 5.5  1.6 for the null mutant, 6.0  1.0 for the
CAI-4 control strain with CIp10, and 5.8  0.4 for the reinte-
grant.)
TABLE 6. Summary statistics of ALS and HYR tandem repeat length estimates for 43 C. albicans isolates
Gene
P value by cladea
Repeat no. for isolates in:




allele Range Median Mode Range Median Mode Range Median Mode Range Median Mode
ALS1 0.062 0.95 9–19 14 14 2–19 12.5 2 11–16 13 13 11–22 14 13
ALS2 
0.001 0.22 10–48 39 39 14–30 27 27 25–30 30 30 11–48 34 39
ALS3 0.078 0.016 8–17 10 10 8–17 13 13 9–13 10.5 13 10–15 11 11
ALS4 0.01 0.90 8–39 25 25 14–34 19 14 22–34 29 29 13–39 29 29
ALS5 0.002 0.071 4–5 4 4 4–10 6 4 4–4 4 4 4–8 4 4
ALS6 
0.001 0.101 3–4 4 4 3–4 3 3 3–4 3 3 4–9 8 8
ALS7 
0.001 0.27 3–26 16 16 3–7 4 4 3–16 3 3 9–27 25 26
ALS9 0.007 0.44 10–20 10 10 11–23 13 13 11–15 11.5 11 7–18 11 11
HYR1 
0.001 0.22 21–25 23 22 21–23 23 23 21–23 22 23 16–25 25 25
HYR3
First repeat 
0.001 0.018 2–4 2 2 2–4 2 2 4–4 4 4 2–4 4 4
Second repeat 
0.001 0.031 21–22 22 22 22–22 22 22 20–21 20 20 21–21 21 21
a Outcome of Kruskall-Wallis test for association between midrepeat numbers and clade, applied to all alleles from all isolates represented separately (single alleles
column) or to the average allele size for each (diploid) isolate.
FIG. 4. Interisolate differences in constitutive gene expression profiles. The figure depicts the GeneSpring interpretation graph for triplicate
expression profiles of two C. albicans isolates each from clades 2 and 3, plus reference isolate SC5314, grown in NGY medium. Each line in the
graph indicates the relative expression level for a single gene. The expression level of the gene in strain AM2003/0100 compared to SC5314 sets
the color of the line, which is kept through all the other strains.
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DISCUSSION
Our study aimed to define possible strain differences be-
tween clinical isolates of C. albicans that might relate to their
virulence in mice and to their assignment to one of the four
major C. albicans clades of related strain types. Because C.
albicans is an opportunistic pathogen, depending more on low-
ered host resistance to infection than on its own inherent
virulence attributes to invade and disseminate, we did not
expect to find self-evident strain-related properties that would
unequivocally associate a particular C. albicans clade or MLST
strain type with differential virulence. We anticipated statistical
associations between strain attributes and virulence or clade
assignment; our data confirmed this expectation.
The basis for clade-level differentiation of C. albicans strains
by MLST is partly arbitrary (40) but reflects at least well-
established geographical associations suggestive of an indepen-
dent evolutionary history for isolates in clades 1 to 4 (40, 48,
51). Isolates from the four major clades should therefore ex-
hibit differences detectable by fine-scale measurement but are
unlikely to show gross phenotypic differences. In common with
previous authors (41, 63), we found statistically significant dif-
ferences in the numbers of midrepeat sequences for ALS3,
ALS5, and ALS6, and we extended the list of genes with clade-
associated variable midrepeat sequences to all the other mem-
bers of the ALS gene family except ALS1 (Table 6) and to
three midrepeat sequences in the genes HYR1 and HYR3 (Ta-
ble 6). Since most of the products encoded by these gene
families are surface proteins with known contributions to ad-
herence of C. albicans to various surfaces (58–62) or to yeast-
hypha morphogenesis (3, 8), the variations in midrepeat allele
lengths between clades might be assumed to contribute to
overall virulence of isolates. However, no associations were
found between the various midrepeat alleles and strain viru-
lence for mice. Since adherence and morphogenesis are phe-
nomena mediated and regulated by many gene products (1, 9,
14, 19, 28, 42), it is likely that C. albicans possesses consider-
able functional redundancy with respect to these properties, so
while differences may arise between adhesin structures within
different strain clades, these are unlikely to translate to detect-
able effects on strain virulence.
Our expression profiling data generated lists of genes with
statistically significant associations with strain clades. Microar-
ray profiling of a complement of more than 6,000 genes with
RNA extracted in triplicate from 20 isolates of a fungus might
easily result in a set of apparently differential genes arising by
chance. Even with appropriate statistical analysis, the sheer
number of data points involved offers considerable opportunity
FIG. 5. Heat maps indicating the average differences in RNA levels
between genes found to be significant interclade differentiators (q 

0.05 by SAM analysis) for 20 C. albicans isolates grown in NGY
medium (a) and in RPMI 1640 medium (b). The heat map colors are
based on pale yellow indicating no upregulation relative to the pooled
SC5314 RNA control. Colors ranging from purple (maximum of 20-
fold) through red and orange indicate RNA levels greater than the
level for the control, while green through pale blue (20-fold downregu-
lation) colors indicate RNA levels below the level for the control. In
both figures, the heat map for SC5314 (mean of triplicate data versus
SC5314 RNA pool) is shown in the leftmost column.
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for artifactual significant differences in gene expression; hence,
we used a highly rigorous approach to data analysis. We com-
pared the SAM outputs from analyses of all triplicate data for
each isolate with the outputs for analyses done with the closest
pair of results for each isolate-gene combination and accepted
from the outputs only genes common to both analyses as po-
tentially significant differentiators at the level of clade or vir-
ulence group. One hypothetical expectation for genes with
expression differing between clades of strains is that at least
some of such genes would encode enzymes in a common bio-
chemical pathway. Our data provide no suggestion of pathway
links between any of the genes emerging as differentially ex-
pressed between different clades (Fig. 5); the significant mul-
ticlass genes listed are all effectively singletons. We have re-
analyzed our expression data with the software package
GALGO (53), which combines Bayesian and multiple regres-
sion approaches to detect sets of genes among expression data
that are differentially associated with grouping strata. The soft-
ware generated a list of genes common with those in Fig. 5 but
did not detect any gene combinations that related to strain
clades (unpublished data). It is clear from Fig. 5 that expres-
sion profiling of none of the genes listed as significant in these
experiments could be reliably used to differentiate new isolates
at the clade level. However, it is unquestionable that individual
isolates of C. albicans can differ markedly in their gene expres-
sion profiles when grown under identical conditions (Fig. 4).
We cannot exclude the possibility that genes apparently ex-
pressed at lower levels in some strains than others may have
DNA sequence differences from those of the oligonucleotides
in the microarray. Resequencing of a well-selected set of iso-
lates could address this possibility. Overall, we interpret our
expression profiles in Fig. 5 as further indication of clade-
associated phenomena that represent statistical rather than
absolute interclade differences. Profiling for isolates grown un-
der different conditions may, of course, reveal other gene sets
that differ between clades.
Among our set of phenotypic properties, levels of acid phos-
phatase activity and ability to grow in 2 M NaCl were the only
parameters significantly associated with strain clades. Average
levels of acid phosphatase activity tended to be lower among
clade 2 isolates than among isolates from other clades, and all
but one of the clade 1 isolates grew in 2 M NaCl compared with
40% in clade 2 and fewer than 20% in clades 3 and 4. Acid
phosphatase activity also emerged as a property associated
with overall strain virulence (discussed below), but clades
themselves were not significantly associated with overall viru-
lence, so we conclude that acid phosphatase should be re-
garded as a weakly differential interclade property. The finding
FIG. 6. Heat map indicating the average differences in RNA levels between genes found to be significant multiclass differentiators between C.
albicans isolates of high (group 1), intermediate (group 2) and low (group 3) virulence in the mouse model (see Table 4). The heat map was set
up as explained in the legend to Fig. 5. CA ref., CA reference.
FIG. 7. Time to euthanasia curves for groups of six mice infected
i.v. with the control strain (NGY152; solid circles), pho100::pho100
mutant strain (DMY002; squares), and pho100::PHO100 reintegrant
strain (DMY003; open circles).
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of generally higher salt tolerance among our clade 1 isolates is
similarly difficult to interpret. Clade 1 isolates represent the
most commonly encountered C. albicans strain types on a
world-wide scale. There have been previous suggestions that
clade 1 isolates may be slightly better adapted than others to
colonize or superficially infect human hosts (17, 38, 40, 46), but
we are not able to suggest how slightly enhanced salt tolerance
might contribute to this situation.
Considered overall, the results of this study relating a diverse
range of properties to C. albicans clades indicate that direct
measurements of genetic diversity, such as determinations of
midrepeat sequence lengths, are more successful than tran-
scriptome data and phenotypic testing at revealing interclade
differences. Clade-level phenotypic properties are apparent,
notably the previously described association of clade 1 isolates
with flucytosine resistance and the present finding of much
greater salt tolerance among clade 1 isolates. However, none
of these represents a characteristic unique to any clade, nor
have there been any demonstrable inherent differences in the
overall murine virulence of strains from different clades, even
in this, the largest examination of interstrain differences in
virulence in mice.
Our data relating properties of individual isolates with vir-
ulence in mice show more robust associations than the analyses
of clade associations. Lower virulence in mice among MAT-
homozygous isolates compared with their MAT-heterozygous
counterparts has been demonstrated previously. In these tests
small numbers of isolates were compared with laboratory-gen-
erated MAT-homozygous mutants alone and in experiments
with competitive challenge designs. Survival was used as the
virulence endpoint (24, 30). Other authors tested a larger
panel of clinical isolates and found a lower virulence among
MAT-homozygous isolates (57). Our data, based on virulence
testing with 43 clinical isolates of C. albicans, fully confirm
these previous findings, since no MAT-homozygous isolates
were among the 18 most virulent we tested (Table 4). In com-
mon with Wu et al. (57), we were unable to confirm a prior
suggestion that MAT / strains might be even less virulent
than a/a types (24). Our results show a mixed distribution of
/ and a/a isolates among the ranks of isolates with interme-
diate and low virulence in mice (Table 4). The lower virulence
of MAT-homozygous isolates is probably a consequence of
homozygosity in other genes adjacent to the MAT locus rather
than a specific MAT-related event (57).
Phosphate uptake and metabolism emerge from our data as
properties associated with mouse virulence in C. albicans. This
conclusion is based on two lines of evidence from this study.
First, a statistically significant association was found between
acid phosphatase activity in vitro and gross virulence of isolates
(Table 4). None of the 14 most virulent isolates had acid
phosphatase specific activities greater than 700 nmol/15 min/
OD600, compared with 7/14 of the least virulent isolates. Sec-
ond, expression of four genes encoding phosphate-specific ac-
tivities was shown as significantly related to mouse virulence
(Fig. 6): PHO84, PHO87, PHO100, and VTC4, which encode
an enzyme involved in phosphate transport, an enzyme in-
volved in phosphate uptake, a phosphomonoesterase, and a
polyphosphate synthase, respectively. Acid phosphatase activ-
ity detectable in intact C. albicans cells was proposed many
years ago as one of several hydrolytic enzymes with theoretical
potential as a virulence factor (10). An inducible phospho-
monoesterase, which can be released from intact cells by treat-
ment with sulfhydryl reagents (18), was one of the first biolog-
ical examples of a highly mannosylated protein with enzyme
activity (39). In assembly 21 of the C. albicans genome data-
base (http://www.candidagenome.org), five acid phosphatase
genes are listed: PHO100, PHO111, PHO112, PHO113, and
PHO114. Of these, only PHO100 is inducible and predicted to
be located on the surface: we presume this encodes the induc-
ible surface enzyme that has been previously purified and char-
acterized (39) and listed as upregulated in expression profiles
of biofilm-forming C. albicans (36). From the C. albicans ge-
nome database and our own literature searches, PHO100 has
not emerged as a significantly differentially regulated gene in
any other studies concerned with C. albicans and virulence.
Deletion of the PHO100 gene in the SC5314 background gen-
erated a mutant with paradoxically elevated acid phosphatase
activity. The mutant showed mild but significant attenuation in
virulence in mice as measured by time to euthanasia, and
animals infected with the mutant had smaller changes in body
weight over the first 3 days postchallenge and the lowest mean
kidney fungal burdens compared to the parental reference and
PHO100 reintegrant strains, but these differences were not
statistically significantly different. The increase in acid phos-
phatase activity in the pho100 mutant is compatible with the
finding of higher acid phosphatase levels in the clinical isolates
with the least virulence in mice (Table 4). We think that more-
detailed investigation of phosphatase activity is warranted in
the context of pathogenesis of C. albicans infections.
The finding of a significant association between gross viru-
lence in mice and an isolate’s growth rate in a tissue culture
medium at 40°C but not at lower temperatures (Table 4) is
compatible with the clinical observation of fever in patients
with disseminated C. albicans infections. However, fever is not
a characteristic of the mouse i.v. challenge model; body tem-
perature tends to fall with progressive disease (49, 56). We are
therefore unable to explain the significance of the high tem-
perature growth rate association with virulence. Monitoring of
body temperature to predict the onset of C. albicans terminal
disease has been recommended in the mouse model (56). Our
own data suggest that mouse body weight change over 3 days
postchallenge is also a useful predictor of survival, since the
two parameters showed a highly significant correlation. We are
currently developing a virulence score based on day 3 weight
changes and kidney burdens that will eliminate the need for
prolonged survival experiments to determine the virulence of
C. albicans strains.
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ADDENDUM IN PROOF
A recent update of the Candida genome database lists CA0636 and
CA0639 as synonyms of CA1253/orf19.1774 and CA3258 as CA3257/
orf19.3746. Since both of these ORFs are already shown in Fig. 6, this
new information strengthens the robustness of the data in Fig. 6.
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